NCT07229638 2026-03-12
A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2 Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
University College, London
Cancer Care Hospital & Research Centre Foundation, Lahore
Amgen
Imperial College London